Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia
Clinical trial NCT03882281 · COMPLETED
Trial details
- NCT number
- NCT03882281
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2019-11-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.